Dr Dan Engle04 September 2021

How MDMA Is Transforming Mental Health - Dr Dan Engle - #367

0Frameworks

9Insights

Insights & moments

The myth-busts, hot takes, explainers, and tools worth keeping.

Myth Buster· 1

Myth Buster31:30

Why MDMA Doesn't Belong in Schedule One

Dr. Dan Engle explains that classifying MDMA as a Schedule One drug—defined as having no medical benefit and high addiction risk—is scientifically inaccurate. Unlike heroin or meth, MDMA is proving highly effective and safe in treating trauma, especially PTSD, and is saving lives rather than endangering them.

MDMA is currently classified as Schedule One in the U.S., alongside drugs like heroin and cocaine.
This classification claims no medical benefit and high abuse potential, which contradicts clinical evidence.
MDMA-assisted therapy shows high success rates in curing chronic PTSD, unlike traditional treatments.
The drug is being re-evaluated as part of a mental health renaissance, with legalization expected within 18–24 months.

“MDMA is saving a lot of people's lives. It's helping people reclaim their trauma so as to be able to grow from it and through…”
Dr. Dan Engle · 37:10

#mdma#mental-health#drug-policy#psychiatry#ptss

Hot Take· 2

Hot Take34:30

The War on Drugs Was About Control, Not Science

Dr. Engle asserts that the war on drugs was politically motivated, targeting minorities and counterculture movements. Nixon’s administration linked Black communities to heroin and hippies to cannabis to justify criminalization and social control, not public health.

The war on drugs was not based on scientific evidence but on political strategy.
Nixon aimed to marginalize Black and anti-war communities by associating them with illegal drugs.
This led to mass incarceration and systemic injustice under the guise of public safety.
Current psychedelic renaissance is part of a broader truth-telling and justice movement.

“The Nixon administration public enemy number one was drugs... But that was still smoking mirrors... They wanted a control mechanism for the minorities.”
Dr. Dan Engle · 35:00

#drug-policy#social-justice#history#nixon#politics

Hot Take90:00

Sustainability Is the Next Frontier in Plant Medicine

Dr. Engle warns that overharvesting of natural psychedelic sources—like peyote, ayahuasca, and Sonoran Desert toad—is threatening ecosystems and Indigenous traditions. He advocates for synthetic alternatives and reciprocal relationships with source communities.

Peyote, iboga, and 5-MeO-DMT are being harvested unsustainably.
Synthetic versions (e.g., lab-made 5-MeO) can preserve species.
Respect for Indigenous knowledge and traditions is essential.
Kuya center aims to give back to communities that steward these medicines.

“We're harvesting at accelerated rates that are stripping out our supply. How do we live sustainably?”
Dr. Dan Engle · 91:00

#sustainability#plant-medicine#indigenous#conservation#ethics

Explainer· 3

Explainer24:30

How MDMA Works in the Brain to Heal Trauma

MDMA creates a unique neurochemical environment that relaxes fear, enhances memory, and boosts self-awareness. By flooding the brain with oxytocin, serotonin, and norepinephrine, it quiets the amygdala, opens communication between brain regions, and allows suppressed trauma to surface safely.

MDMA releases oxytocin, promoting feelings of bonding and safety.
It reduces amygdala activity, lowering fear and defensiveness.
Prefrontal cortex activation improves self-observation and clarity during therapy.
Enhanced hippocampal connectivity strengthens memory recall, aiding trauma processing.

“It releases and floods the system with something called oxytocin. Oxytocin is our bonding hormone.”
Dr. Dan Engle · 25:00

“I've relaxed my fear center. The amygdala is down regulated. I have a better witness cuz the prefrontal cortex is online, and I have better…”
Dr. Dan Engle · 26:50

#mdma#neurochemistry#trauma#psychotherapy#brain

Explainer07:30

The Three Levels of Psychedelic Medicines

Dr. Engle categorizes psychedelic experiences into three levels based on intensity and support needs. Level One includes MDMA, ketamine, and low-dose psilocybin; Level Two includes ayahuasca and peyote; Level Three includes DMT and iboga, which require extensive preparation and expert facilitation.

Level One medicines are easier to navigate and often require only a trained sitter.
Level Two involve group ceremonies and deeper spiritual work, requiring experienced facilitators.
Level Three are intense, long-lasting experiences like iboga (up to 40 hours) and DMT, which can 'blow the doors off' consciousness.
Progression should follow a ladder: foundational practices first, then deeper medicines.

“Level one medicines are typically easier to navigate and with a higher likelihood of having a positive experience if you only had a sitter supporting…”
Dr. Dan Engle · 15:00

#psychedelics#ayahuasca#iboga#dm-t#therapeutic-framework

Explainer10:00

Complex PTSD vs. Classic PTSD: Origins and Prevalence

Dr. Engle distinguishes between classic PTSD—often from war or accidents—and complex PTSD, which stems from early childhood adversity, including pre-verbal trauma. He estimates 60–70% of trauma cases are complex PTSD, rooted in subtle, cumulative emotional erosion.

Classic PTSD results from acute, life-threatening events.
Complex PTSD arises from chronic emotional neglect or abuse in childhood.
Much of this trauma occurs before age 4–5, before language and memory fully develop.
Erosion of trust in caregivers or authority figures can have lifelong psychological effects.

“Trauma doesn't have to mean like being in war and on the battlefield... There's also this growing awareness... of what we would call complex PTSD.”
Dr. Dan Engle · 10:00

#ptsd#trauma#childhood#mental-health#psychology

Q&A· 1

Q&A18:00

Why Therapeutic MDMA Feels Like a Different Molecule

When used recreationally with alcohol and in social settings, MDMA creates euphoria and connection. But in therapy, with intention and support, it becomes a profound tool for trauma healing—so different that users often say it feels like a different substance.

Set, setting, and intention dramatically alter the MDMA experience.
Recreational use focuses on external stimulation (music, dancing).
Therapeutic use turns attention inward, unlocking repressed memories.
Alcohol impairs memory and undermines therapeutic potential.

“The experience between a recreational process and a therapeutic process felt to them like it was a totally different molecule that they're working with.”
Dr. Dan Engle · 19:00

#mdma#set-and-setting#therapy#intention#integration

Tool· 1

Tool47:30

Iboga: The Most Effective Medicine for Addiction

Dr. Engle describes iboga as the most powerful single agent for addiction recovery, particularly for opioids. It resets brain chemistry, eliminating cravings and withdrawal symptoms in 75–80% of users, and provides deep psychological insight through its long-duration visionary experience.

Iboga lasts 18–36 hours, sometimes up to 40 hours.
It resets opioid receptors, stopping cravings and withdrawal.
Works on over 50 receptor systems, acting like a 'Brillo pad' in the brain.
Used traditionally and clinically for addiction and trauma healing.

“Iboga is the best medicine for addiction recovery on the planet, period. The best single agent.”
Dr. Dan Engle · 49:00

#iboga#addiction#recovery#medicine#trauma

Takeaway· 1

Takeaway76:30

Integration Is 60% of the Healing Work

Dr. Engle emphasizes that lasting change comes not from the psychedelic experience itself, but from integration—making sense of insights and acting on them. He estimates 50–60% of the healing happens after the session through community, accountability, and daily practice.

Preparation: 5–10%, Experience: 30–40%, Integration: 50–60%.
Without integration, insights are lost and trauma may resurface.
Accountability structures and supportive communities are essential.
The 'genie is out of the bottle'—you can't unsee what you've learned.

“The majority of the work happens in the integration because that's where we make lasting change.”
Dr. Dan Engle · 77:00

#integration#psychedelic-therapy#healing#mindfulness#growth